氯胺酮与依托咪酯在气管插管患者中与插管后低血压无更多关联
本研究为回顾性队列研究,纳入2016年1月1日至2019年6月30日期间在某大型学术医疗系统急诊科接受急诊气管插管的469例患者中的358例(依托咪酯272例,氯胺酮86例),主要终点为插管后低血压(收缩压<90 mmHg或平均动脉压<65 mmHg)。结果显示,氯胺酮组插管前休克指数均值高于依托咪酯组(0.97 vs 0.83,差值-0.14,95%CI -0.2至-0.1),插管后低血压发生率在休克指数分层前氯胺酮组更高(差值-10%,95%CI -20.9%至-0.1%)。多因素logistic回归显示,诱导剂选择与插管后低血压无关(aOR 1.45,95%CI 0.79至2.65),插管前休克指数是插管后低血压的最强预测因子。结论提示,休克指数升高的患者无论使用氯胺酮还是依托咪酯,心血管衰竭风险均较高。
要点
- 在急诊气管插管患者中,多因素logistic回归显示诱导剂选择(氯胺酮 vs 依托咪酯)与插管后低血压无关(aOR 1.45,95%CI 0.79至2.65)。
- 插管前休克指数是插管后低血压的最强预测因子。
- 氯胺酮组插管前休克指数均值高于依托咪酯组(0.97 vs 0.83,差值-0.14,95%CI -0.2至-0.1)。
- 休克指数分层前,氯胺酮组插管后低血压发生率高于依托咪酯组(差值-10%,95%CI -20.9%至-0.1%)。
- 急诊医师更倾向于对休克指数>0.9的患者使用氯胺酮。
适用人群与场景
- 急诊科接受急诊气管插管的成人患者(≥18岁)。
- 排除标准:<18岁、在急诊科以外行气管插管、围插管期生命体征不完整、插管前心跳骤停。
- 高血流动力学崩溃风险患者通过插管前休克指数>0.9识别。
诊断标准与关键阈值
- 插管后低血压定义:收缩压<90 mmHg或平均动脉压<65 mmHg。
- 高血流动力学崩溃风险:插管前休克指数>0.9。
红旗征与不能漏的情况
- 插管前休克指数升高(>0.9)提示插管后心血管衰竭风险较高,无论选择氯胺酮还是依托咪酯。
研究设计与关键结果
- 研究类型:回顾性队列研究,纳入358例患者(依托咪酯272例,氯胺酮86例),来自某大型学术医疗系统2016年1月1日至2019年6月30日的电子健康记录。
- 主要终点:插管后低血压发生率在休克指数分层前氯胺酮组高于依托咪酯组(差值-10%,95%CI -20.9%至-0.1%)。
- 多因素logistic回归:诱导剂选择与插管后低血压无关(aOR 1.45,95%CI 0.79至2.65)。
- 插管前休克指数是插管后低血压的最强预测因子。
- 氯胺酮组插管前休克指数均值高于依托咪酯组(0.97 vs 0.83,差值-0.14,95%CI -0.2至-0.1)。
- 急诊医师更倾向于对休克指数>0.9的患者使用氯胺酮。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于急诊气管插管患者,选择氯胺酮或依托咪酯诱导与插管后低血压风险无关,但插管前休克指数升高的患者心血管衰竭风险较高,需关注。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Emergency department (ED) patients undergoing emergent tracheal intubation often have multiple physiologic derangements putting them at risk for post-intubation hypotension. Prior work has shown that post-intubation hypotension is independently associated with increased morbidity and mortality. The choice of induction agent may be associated with post-intubation hypotension. Etomidate and ketamine are two of the most commonly used agents in the ED, however, there is controversy regarding whether either agent is superior in the setting of hemodynamic instability. The goal of this study is to determine whether there is a difference in the rate of post-intubation hypotension who received either ketamine or etomidate for induction. Additionally, we provide a subgroup analysis of patients at pre-existing risk of cardiovascular collapse (identified by pre-intubation shock index (SI) > 0.9) to determine if differences in rates of post-intubation hypotension exist as a function of sedative choice administered during tracheal intubation in these high-risk patients. We hypothesize that there is no difference in the incidence of post-intubation hypotension in patients who receive ketamine versus etomidate.
METHODS: A retrospective cohort study was conducted on a database of 469 patients having undergone emergent intubation with either etomidate or ketamine induction at a large academic health system. Patients were identified by automatic query of the electronic health records from 1/1/2016-6/30/2019. Exclusion criteria were patients <18-years-old, tracheal intubation performed outside of the ED, incomplete peri-intubation vital signs, or cardiac arrest prior to intubation. Patients at high risk for hemodynamic collapse in the post-intubation period were identified by a pre-intubation SI > 0.9. The primary outcome was the incidence of post-intubation hypotension (systolic blood pressure < 90 mmHg or mean arterial pressure < 65 mmHg). Secondary outcomes included post-intubation vasopressor use and mortality. These analyses were performed on the full cohort and an exploratory analysis in patients with SI > 0.9. We also report adjusted odds ratios (aOR) from a multivariable logistic regression model of the entire cohort controlling for plausible confounding variables to determine independent factors associated with post-intubation hypotension.
RESULTS: A total of 358 patients were included (etomidate: 272; ketamine: 86). The mean pre-intubation SI was higher in the group that received ketamine than etomidate, (0.97 vs. 0.83, difference: -0.14 (95%, CI -0.2 to -0.1). The incidence of post-intubation hypotension was greater in the ketamine group prior to SI stratification (difference: -10%, 95% CI -20.9% to -0.1%). Emergency physicians were more likely to use ketamine in patients with SI > 0.9. In our multivariate logistic regression analysis, choice of induction agent was not associated with post-intubation hypotension (aOR 1.45, 95% CI 0.79 to 2.65). We found that pre-intubation shock index was the strongest predictor of post-intubation hypotension.
CONCLUSION: In our cohort of patients undergoing emergent tracheal intubation, ketamine was used more often for patients with an elevated shock index. We did not identify an association between the incidence of post-intubation hypotension and induction agent between ketamine and etomidate. Patients with an elevated shock index were at higher risk of cardiovascular collapse regardless of the choice of ketamine or etomidate.
参考来源
- Foster M, Self M, Gelber A, et al. Ketamine is not associated with more post-intubation hypotension than etomidate in patients undergoing endotracheal intubation. Am J Emerg Med. 2022. PMID: 36096015. doi:10.1016/j.ajem.2022.08.054
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。